J. Goldman & Co’s Amgen AMGN Stock Holding History

J. Goldman & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.48M	Sell	9,900 -33,588	-77%	-$12M	0.1%	236
2025 Q4	$14.2M	Sell	43,488 -29,314	-40%	-$9.3M	0.37%	72
2025 Q3	$20.5M	Buy	+72,802	New	+$21.1M	0.52%	51
2024 Q4	–	Sell	-53,446	Closed	-$17.2M	–	449
2024 Q3	$17.2M	Sell	53,446 -3,428	-6%	-$1.12M	0.48%	55
2024 Q2	$17.8M	Buy	56,874 +16,465	+41%	+$4.84M	0.5%	60
2024 Q1	$11.5M	Sell	40,409 -10,325	-20%	-$3.02M	0.37%	89
2023 Q4	$14.6M	Sell	50,734 -52,803	-51%	-$14.4M	0.59%	56
2023 Q3	$27.8M	Buy	+103,537	New	+$25.8M	0.97%	27
2022 Q4	–	Sell	-28,681	Closed	-$6.46M	–	368
2022 Q3	$6.46M	Buy	28,681 +7,909	+38%	+$1.92M	0.31%	96
2022 Q2	$5.05M	Buy	+20,772	New	+$5.09M	0.25%	104

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

J. Goldman & Co's AMGN Position: Q1 2026 in Review

J. Goldman & Co reduced its Amgen (AMGN) stake by 77% in Q1 2026, selling an estimated $12M and leaving 9,900 shares worth $3.48M. The position accounts for 0.1% of the portfolio, ranked #236.

J. Goldman & Co first reported a position in AMGN in Q2 2022 and has held it in 10 quarters since. The position peaked at $27.8M in Q3 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

J. Goldman & Co held 9,900 shares of Amgen worth $3.48M as of Q1 2026.
J. Goldman & Co sold 33,588 Amgen shares in Q1 2026, an estimated $12M.
Amgen made up 0.1% of J. Goldman & Co's portfolio in Q1 2026, its #236 holding.
J. Goldman & Co first reported a position in Amgen in Q2 2022 and has held it in 10 quarters since.
J. Goldman & Co's Amgen position peaked at $27.8M in Q3 2023.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.